fda warning letter semaglutide october 2025 warns Ozempic and Wegovy maker over unreported GLP-1 side effects Oral Semaglutide Approved to Reduce

Health Canada's authorization of generic semaglutide marks a turning point, not just for Hims & Hers customers, but for the country's broader healthcare landscape

Protein pacing spreads daily protein intake across smaller meals, making it easier for people on GLP-1 medications to meet protein needs despite reduced appetite

Keeping this in a regulated pharmacy is not the risk in the room

We offer provider-led bioidentical hormone replacement therapy and GLP-1 medications

Conversely, the American Gastroenterological Association (AGA) suggests proceeding with planned procedures for patients adhering to standard pre-procedure precautions